Harrow (HROW) FCF Margin Growth (3y) (2016 - 2026)
Harrow (HROW) FCF Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 213.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 2,102.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 180.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1,592.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -291.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -2,476.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 1,604.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Harrow | 1.53 Bn | 1.45 Bn | 50.36 Mn | -2,740.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,740.00 |
| Mar 31, 2026 | 1,259.00 |
| Dec 31, 2025 | 3,164.00 |
| Sep 30, 2025 | 2,899.00 |
| Jun 30, 2025 | -2,092.00 |
| Mar 31, 2025 | 3,822.00 |
| Dec 31, 2024 | -2,067.00 |
| Sep 30, 2024 | 1,836.00 |
| Jun 30, 2024 | -2,918.00 |
| Mar 31, 2024 | -3,304.00 |
| Dec 31, 2023 | 2,783.00 |
| Sep 30, 2023 | -2,371.00 |
| Jun 30, 2023 | 5,159.00 |
| Mar 31, 2023 | -2,685.00 |
| Dec 31, 2022 | -2,871.00 |
| Sep 30, 2022 | -568.00 |
| Jun 30, 2022 | 1,608.00 |
| Mar 31, 2022 | 1,629.00 |
| Dec 31, 2021 | -159.00 |
| Sep 30, 2021 | -1,082.00 |